Prospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Sep 28, 2016; 8(27): 1149-1154
Published online Sep 28, 2016. doi: 10.4254/wjh.v8.i27.1149
Table 2 Characteristics of study patients and controls
PatientsControls
At listing
n3672
Age, median (IQR)58 (14)60 (11)
Male, n (%)23 (64)46 (64)
INR, median (IQR)1.8 (0.6)1.9 (0.7)
Total Bilirubin, median (IQR)8.9 (19.3)5 (7.7)
Creatinine, median (IQR)2.1 (2.4)1.5 (2)
Albumin, median (IQR)3.2 (0.9)2.9 (1)
MELD, median (IQR)27 (11)24 (11)
At transplant
n1938
Age, median (IQR)56 (17)55 (13)
Male, n (%)13 (68)26 (68)
INR, median (IQR)1.6 (0.5)1.9 (0.8)
Total Bilirubin, median (IQR)8.3 (12.1)6 (5.7)
Creatinine, median (IQR)2.6 (2.9)1.3 (1.3)
Albumin, median (IQR)2.9 (0.8)2.8 (1)
MELD, median (IQR)24 (13)25 (9)